🇺🇸

M&A Activity

US SEC Filing Intelligence · 169 digests

New to these filings? Learn what an 8-K is · what a Form 425 merger communication is

· daily

US Merger & Acquisition SEC Filings — October 30, 2026

The October 30, 2026 M&A tape is dominated by distressed and blank-check activity rather than strategic going-concern deals: 5 of 8 filings involve SPAC extension mechanics or IPO plumbing, 2 involve asset sales (one a Chapter 11 liquidation to Teva, one a related-party liquidation of an operating business), and only 1 is a genuine strategic acquisition (Edible Garden's $6.3M Prairie Hills facility). The most material event is BioXcel's final bankruptcy court approval of its asset sale to Teva Pharmaceuticals International GmbH (Case No. 26-11360, D. Del.), converting a failed biotech into a liquidation recovery story with no disclosed consideration. Zoned Properties' related-party sale to an entity owned by its own CEO/Chairman/CFO and President/COO is a governance red flag even as pro forma stockholders' equity rises to $10.79M from $3.43M and liabilities collapse from $10.05M to $0.32M — but pro forma revenue drops to $0 from $1.95M and net income swings to a -$996,935 loss from +$19,127, meaning equity value is now a disposal-gain artifact, not an earnings stream. SPAC stress is visible across the cohort: K&F Growth Acquisition Corp. II cut its completion runway by ~18 months (Feb 2028 to Aug 2027), Copley Acquisition Corp adjourned its EGM to Nov 2 and sweetened sponsor contributions from $150K to $200K/month to buy back dissenting votes, and Constellation Acquisition Corp I is on its ninth of eleven permitted extensions — a pattern that signals a late-cycle SPAC market with rising redemption pressure and shrinking deal optionality. Edible Garden's all-non-cash $6.325M purchase (2,500 Series B preferred at $2.5M plus a $3.825M 8% Streeterville note) adds capacity but layers on expensive, daily-compounded debt and preferred equity, a financing structure that flags balance-sheet strain. Net takeaway: the actionable intelligence is in distressed recovery (Teva/BioXcel), governance risk (Zoned), and SPAC catalyst timing (Copley Nov 2, K&F Nov 3, Constellation Nov 29) rather than in growth M&A.

8 high priority 8 total filings
· daily

US Merger & Acquisition SEC Filings — October 29, 2026

The US M&A & Takeover Activity stream for October 29, 2026, is dominated by SPAC lifecycle events and a strategic divestiture. UNIFI Inc. completed a $60 million sale of non-strategic real estate, using net proceeds to fully repay its $55.5 million term loan, deleveraging its balance sheet and improving liquidity without impacting production capacity. Among SPACs, Lakeshore Acquisition III Corp. received a fourth $67,500 extension payment from CPRO Korea, pushing its merger deadline to December 1, 2026, signaling persistent delays but continued counterparty commitment. Inflection Point Acquisition Corp. VI achieved SEC effectiveness of its Form S-4 for the Quantum Space combination, a critical milestone that brings the deal closer to a shareholder vote, though the target's flagship vehicle remains pre-revenue. Rising Dragon Acquisition Corp. issued an $11,188.68 promissory note to SZG Limited to fund a trust extension, highlighting ongoing financing needs for its January 2025 merger agreement. Overall, the filings reflect a mix of balance-sheet strengthening and SPAC deal progression, with no period-over-period financial comparisons or insider activity disclosed, limiting trend analysis. The absence of insider transactions and capital allocation updates suggests a quiet period for management conviction signals.

4 high priority 4 total filings
· daily

US Merger & Acquisition SEC Filings — October 28, 2026

Across the eight filings for the USA M&A & Takeover Activity stream (all dated 2026-10-28), activity centers on SPAC mechanics and one completed operating-company acquisition. Enerpac Tool Group's $472 million SFE Group purchase is the only true industrial M&A event: it implies 10.6x trailing adjusted EBITDA (9.5x with synergies) and lifts pro forma net debt-to-adjusted EBITDA to roughly 2.3x, making it the most material item in the set. The remaining seven filings are blank-check or SPAC-related and show a common pattern of sponsor-funded extensions, related-party payments outside trust accounts, Nasdaq compliance deficiencies, and auditor changes. Period-over-period comparisons are largely unavailable because most filers are pre-combination shells, so trend analysis is limited to the operating target SFE Group and the Elroy Air deal's pipeline disclosures. The dominant market implication is that SPAC sponsors are increasingly financing deadline extensions and insider compensation with sponsor capital, raising dilution and governance questions for public holders. Scope note: SPAC-only filings are retained because they fall squarely within the Merger/Acquisition and takeover focus.

8 high priority 8 total filings
· daily

US Merger & Acquisition SEC Filings — October 27, 2026

This M&A and takeover stream captures a heavy day of corporate combination activity on October 27, 2026, spanning large-cap strategic deals, reverse mergers, a spin-off, and micro-cap licensing transactions. The largest signal is Vertiv's roughly $1.45 billion upfront plus up to $1.15 billion earnout for Utility Innovation Holdings, priced near 13x expected 2027 EBITDA and framed around AI data center grid-interconnect constraints. Alamo Group (Econ Engineering, about $158.7 million, roughly 44% EBITDA margin) and GrabAGun (Camfour, about $34.0 million cash-free, debt-free) reflect bolt-on acquisitions of niche, cash-generative distributors and manufacturers. Several filings show a consistent pattern of mixed reported results: Manhattan Associates posted record Q3 revenue (+11% YoY, Cloud +28%) yet operating cash flow fell 26% and DSO rose from 67 to 81 days, while MSG Knickerbockers' spin-off of MSGR cut pro forma revenue from $1,153.8 million to $816.6 million. Micro-cap and SPAC-style transactions (Ecominas, SecureTech, ATII/Forge Nano, Cayson) carry going-concern, dilution, and shell-company disclosures that warrant skepticism. Overall, the stream points to strategic buyers using cash on hand and revolvers for accretive tuck-ins, while reverse recapitalizations and preferred-share consideration dominate the small-cap tail.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — October 26, 2026

Across the 17 filings, M&A and SPAC-related activity dominated, with a mix of completed deals, pending combinations, and SPAC deadline and governance events. The clearest completed transaction is Francisco Partners' ~$650M all-cash take-private of Weave Communications at $7.40/share (~34% premium to the unaffected August 17, 2026 close), which is the most valuation-relevant development in the set. SPAC activity is bifurcated: Amanat/Corxel (~$377M gross proceeds, first-half 2027 close) and Senti Biosciences' CVR-only divestiture show deal flow, while Bold Eagle, Oaktree III and K&F II face deadline extensions or structural changes, and YHN Acquisition I faces Nasdaq delisting. Period-over-period data is sparse for deal filings; the only quantified comparisons come from Ponce Financial (Q3 2026 net income of $18.0M vs $8.2M QoQ, but with declining capital ratios) and Senti's pro forma reduction in total assets from $33.1M to $3.2M. Several filings (Nathan's Famous, Boston Omaha, Unitil, Faraday/FFR) carry transaction disclosures but limited verifiable financials, so conclusions there are provisional. Overall, the theme is redemption and deadline pressure across the SPAC cohort alongside selective strategic exits and take-privates.

17 high priority 17 total filings
· daily

US Merger & Acquisition SEC Filings — October 23, 2026

Across the 15 filings dated 2026-10-23, the dominant theme is SPAC lifecycle stress and resolution: multiple blank-check vehicles are burning through extension rights (International Media at its 23rd of 24 extensions, Black Hawk, Ribbon), funding deadline extensions with trust deposits, and facing Nasdaq warrant deficiency notices (ARC Group). Against that backdrop, two near-term deal closings stand out: Melar/Everli (shareholders approved all eight proposals with 3,852,564 Class A shares redeemed, leaving roughly $0.8M in trust) and Unusual Machines' completed DroneNX/Upgrade Energy acquisition, while Blue Acquisition's Blockfusion vote is set for November 17, 2026. The most material operating-company event is 1-800-Flowers' $45.0M divestiture of its Personalization Businesses to PlanetArt, which removes roughly 9.7% of FY2026 net revenues and cuts pro forma long-term debt from $112.2M to $91.0M, a deleveraging move rather than an earnings driver. The most dilutive transaction is Bolt Biotherapeutics' reverse merger with Prana Therapies, where pre-deal Bolt holders will own only about 6.9% of common stock versus 51.7% for Prana holders and 41.4% for placement investors. Portfolio-level data is thin: most filings disclose no purchase prices, insider activity, or forward guidance, so period-over-period comparisons are available only for 1-800-Flowers and limited pro forma balance sheet data.

15 high priority 15 total filings
· daily

US Merger & Acquisition SEC Filings — October 22, 2026

The October 22, 2026 M&A and takeover stream is dominated by SPAC activity: of the 15 filings, roughly eight concern blank-check vehicles dealing with trust extensions, sponsor financing, Nasdaq compliance, charter amendments, IPO closings, or deal letters. Only a handful represent substantive operating-company M&A: Data I/O's ~$23 million V-TEK acquisition (expected to roughly double revenue), XCF Global's completed all-stock combination with Southern Energy and DevvStream, Janel's $17 million Encor Biotechnology sale, and NightFood's closed AOI technology acquisition. The enriched period-over-period and forward-looking fields are sparse across this set, so quantitative trend comparisons are limited; where data exists, XCF's 2027 outlook (gross product sales $650-700M, net revenue $120-130M, EBITDA $70-75M) and Data I/O's revenue-doubling claim are the most material. The clearest theme is distress and deadline pressure among small SPACs: Globa Terra faces a Nasdaq delisting with a hearing request due October 23, while ARC Group and Charlton Aria are working against warrant-value and extension deadlines. Deal-quality concerns cluster around unconfirmed targets (NightFood) and unresolved disputes at acquired operations (XCF's New Rise subsidiary). Overall tone is cautious, with positive strategic announcements tempered by financing, compliance, and execution risk.

15 high priority 15 total filings
· daily

US Merger & Acquisition SEC Filings — October 21, 2026

Across the ten filings dated October 21, 2026, M&A activity spans SPAC combinations, operating-company acquisitions, and governance restructurings, with nearly every deal structured around contingencies, deferred consideration, or convertible instruments. The most material developments are Group 1 Automotive's $1.08B Blue Sky acquisition (completed, positive, 9/10), APEX Tech's $3.5B pre-money merger with Korai Flix (8/10), and Nuburu's EUR 5.2M Tekne implementation agreement paired with a EUR 27.7M shareholder-loan exposure and possible Italian capital-impairment measures (8/10). Smith & Wesson's Savage Arms closing (7.9x Adjusted EBITDA, roughly $0.07 FY2027 EPS accretion, 1.16x pro forma net leverage) is the cleanest financially quantified deal in the set, while the SPAC-related filings (Drugs Made In America, Silicon Valley Acquisition, Starry Sea, Pine Tree, Frazier Life Sciences II) are primarily structural and carry dilution, contingency, or reversion risk rather than reported performance. The enriched data available for this batch does not include the period-over-period revenue, margin, insider-transaction, or dividend/buyback series needed for a robust cross-company trend comparison, so portfolio-level conclusions are drawn from transaction terms and structural features rather than quantified YoY/QoQ deltas. Market implication: investors should price contingent and dilutive structures (SPAC conversions, Nuburu deferrals, Olenox preferred consideration) at a discount to headline values until closing and financing conditions are verified.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — October 20, 2026

Across the ten filings, the dominant theme is SPAC lifecycle stress in the US M&A stream: five SPAC filings (Texas Ventures III, ASPAC III, Quartzsea, Healthcare AI, Launch Two, Bold Eagle, Mountain Crest V) center on deadline extensions, charter amendments, or post-redemption survival, signaling that blank-check vehicles are running out of time and relying on sponsor-funded trust deposits and shareholder votes. The most material transaction is Dream Finders Homes' roughly $2.2 billion all-cash acquisition of Beazer Homes at $33.50 per share, which promises over $100 million in run-rate cost synergies and double-digit year-one EPS accretion but explicitly implies leverage will rise before returning to target within 18 to 24 months. Healthcare AI Acquisition's proposed extension to October 2027 with monthly $0.10 per share trust deposits is the highest-materiality SPAC event and is effectively a going-concern precondition, since its existing deadline is October 14, 2026. Quantitative period-over-period data is sparse: Bluerock Homes' pro forma figures show a modest widening of net loss to $(6,963) thousand from $(6,915) thousand and a revenue decline to $38,972 thousand from $39,028 thousand, while the remaining filings contain no financial results. Sentiment is largely neutral with several mixed readings tied to deal financing or deadline-driven liquidation risk. Two filings (Bluerock Homes, Beazer's own 8-K exhibit) are only partially verifiable from the supplied excerpts.

10 high priority 10 total filings
· daily

US Merger & Acquisition SEC Filings — October 19, 2026

Across the 12 filings for the USA M&A & Takeover Activity stream (dated 2026-10-19), the dominant theme is SPAC-driven deal flow and the restructuring of distressed or failing businesses, rather than large strategic acquisitions. TCGX Acquisition Corp. announced the most material transaction, a definitive business combination with clinical-stage biotech TriGemX Bio targeting roughly $246 million in gross proceeds and a ~$600 million post-deal equity value, with closing expected Q1 2027. Several SPACs are under extension or redemption pressure: WinVest extended its deadline by one month via a $30,000 sponsor drawdown, Starry Sea postponed its shareholder meeting after 3.9 million public shares were tendered for redemption, and Apogee is restating its Q2 2026 10-Q after an audit committee finding, with an accompanying board and COO departure. Distressed situations are prominent: Cambium Networks' UK subsidiary is selling its going-concern business to Univastu out of administration, Rocky Mountain Chocolate Factory's strategic committee is exploring a sale or going-private transaction while its liquidity deteriorated sharply (cash $416K, current liabilities $13.6M), and Vivos Therapeutics is using preferred stock to shore up equity against Nasdaq compliance requirements. Limited quantitative period-over-period data was supplied for most filings, so trend analysis is constrained; where data exists it points to deteriorating balance sheets among target-like companies, while SPAC activity is mostly procedural.

12 high priority 12 total filings
· daily

US Merger & Acquisition SEC Filings — October 16, 2026

The USA M&A & Takeover Activity stream for October 16, 2026 is dominated by one material completed transaction: Copart's closing of its acquisition of ACV Auctions at $10.50 per share in cash, with roughly 68.43% of ACV shares tendered before the October 15 expiry. The remaining four filings are mostly housekeeping or smaller-cap SPAC and micro-cap events: a postponed SPAC extension meeting (Oaktree Acquisition Corp. III Life Sciences), a fifth SPAC deadline extension (Bayview Acquisition Corp), a board resignation at a blank-check company (Averin Capital), and a micro-cap asset purchase (AIBOTICS) that carries heavy share dilution. Period-over-period enriched fields were limited in these filings, so cross-company trend analysis is thin; the clearest quantitative anchors are the $10.50 cash price, the 68.43% tender level, the 100 million share grant to the Moore employees, and the $3 million maximum earn-out. The dominant theme is consolidation in the auction and marketplace space, contrasted with SPAC sponsors stretching timelines, which signals financing and deal-completion pressure among blank-check vehicles. Averin Capital's filing was pre-classified as Merger/Acquisition but contains no M&A content and is treated as out of scope.

5 high priority 5 total filings
· daily

US Merger & Acquisition SEC Filings — October 15, 2026

Across the 12 filings for the USA M&A & Takeover Activity stream, the dominant theme is SPAC lifecycle management: deadline extensions, redemptions, and trust-account mechanics (Everest Consolidator, Oaktree Acquisition Corp. III, byNordic, Athena Technology II, IB Acquisition, New America Acquisition I, Pine Tree). Only three filings describe actual deal activity with substance: Pyrophyte Acquisition Corp. II's definitive agreement with Sakuu at a $600M pre-money valuation, SPACSphere's amended Business Combination Agreement with Mobilewalla, and Melar's pending Everli merger, plus Cronos Group's completed CanAdelaar acquisition. The Cronos deal is the most informative on valuation discipline: a €57.5M base price (about 2.9x annualized Adjusted EBITDA) paired with a target whose EBITDA fell from €24.2M to €20.1M, highlighting the risk of buying into a deteriorating asset. The period-over-period data is thin because most filings are procedural, so portfolio-level trend conclusions are limited; the clearest quantitative signal is redemption pressure, with Oaktree III seeing 13.3M Class A shares tendered for redemption before its extension vote. Overall, the stream reflects a SPAC market still working through prior-cycle vintages while selectively advancing new combinations.

12 high priority 12 total filings
· daily

US Merger & Acquisition SEC Filings — October 14, 2026

This M&A and takeover digest covers 12 filings dated 2026-10-14, of which 9 are new and 3 are context. The dominant theme is SPAC activity: Pioneer Acquisition I (Green AI Cloud, $300M pre-money), FortuneX (WT Realty, fixed $525M equity value), Alpha Star (extension to Dec 2027), Pine Tree ($100M IPO), and Future Vision II (monthly extension loans) show the SPAC cohort still active but reliant on repeated extensions and sponsor-funded trust top-ups, with redemption risk embedded in each. Clear Channel's ~$6.2B take-private by Mubadala Capital closed with a CEO change, while Flex completed the EPC Power acquisition ahead of its planned Q1 2027 Axiom spin-off, the clearest strategic-simplification signal in the set. Financing stress is visible at SKYX, which took on $8.5M of 12% first-lien secured debt to close the Deako merger, and at CleanCore/ZONE, where pro forma continuing operations have no revenue and a $(40.1)M operating loss driven largely by digital-asset fair-value losses. Eton's LIBERVANT license lacks disclosed economics, and StageWise shows high percentage revenue growth off a tiny base alongside a going-concern warning. Net: deal flow is real but heavily dependent on extensions, financing and disclosure that often omits price or terms.

12 high priority 12 total filings
· daily

US Merger & Acquisition SEC Filings — October 13, 2026

Across the 21 filings in this window, the dominant theme is SPAC lifecycle stress in the M&A stream: deadline-driven extensions, heavy redemptions, delistings, and terminated or restructured deals. Quetta Acquisition Corp appears three times, with a Nasdaq delisting notice and trading suspension effective October 14, 2026, a 96% redemption leaving only 149,860 shares, and a one-month trust extension to November 10, 2026. Redemption pressure is also visible at Black Hawk (about 50% of shares redeemed at ~$12.04) and Starry Sea (4.28M public shares tendered, forcing a meeting postponement to October 19). Copley Acquisition's mutual termination with Ignite Proteomics is the clearest negative deal-break event, while Alaunos/Velaris ($350M PIPE, preclinical pipeline) and Dot Ai/Envoy (all-stock, BladeRanger majority control) are large, high-dilution transactions with significant execution risk. The most substantive operating data comes from the Sizzle II/Trasteel disclosures, which show H1 2026 revenue +40.0% YoY, EBITDA +80.8% YoY, and reaffirmed FY2026 guidance, though all figures are unaudited management accounts. Several filings (Eureka, M Evo II, Iron Horse II, Quetta extension) are procedural and carry little investable signal; the enriched data for these filings does not contain period comparisons, insider activity, or capital allocation metrics, so conclusions are limited to deal structure and governance. Overall, the window reads as a late-cycle SPAC market where sponsor economics, redemption rates, and financing dilution matter more than headline valuations.

21 high priority 21 total filings
· daily

US Merger & Acquisition SEC Filings — October 09, 2026

Across the 11 filings dated October 9, 2026, the dominant theme is SPAC activity: four SPAC-related 8-Ks (Launch Two, Copley, Iron Horse II, Starry Sea) and one SPAC director resignation (Plum IV) show a sector in extension, redemption, and deal-completion mode, with redemption deadlines and shareholder meetings clustered in mid-to-late October. The most material development is the Evernorth/Armada II business combination (materiality 9/10), where 18.46 million SPAC public shares (about 80% of the public float) were redeemed for roughly $193.6 million, leaving about $47.6 million released to Pubco and 4.54 million public shares outstanding; combined pro forma assets of about $425.2 million are dominated by $349.1 million of XRP, with an unrecorded potential $6.9 million impairment flagged. TruGolf's Polymath acquisition (materiality 8/10) carries a complex post-closing structure with a 19.99% ownership cap and a Series C conversion gated by stockholder and Nasdaq approvals. Among operating-company deals, Ranger Energy's roughly $27.5 million asset purchase and Hepion's Gravitas acquisition (price undisclosed in the excerpt) are small and lack disclosed financial metrics, so their impact cannot yet be assessed. Ashford Hospitality's disposition of a single hotel for about $25.2 million does little to address a pro forma stockholders' deficit of $(569.9) million and $274.0 million of debt tied to receivership hotels. Period-over-period comparisons are largely absent in this set of filings; the enriched insider, guidance, and capital-allocation fields carry no meaningful data for most issuers, so trend synthesis is limited and conclusions rest mainly on transaction structure and redemption mechanics.

11 high priority 11 total filings
· daily

US Merger & Acquisition SEC Filings — October 08, 2026

This M&A and takeover stream covers nine 8-K filings dated October 7-8, 2026, dominated by SPAC activity: four SPAC-related filings concern IPO closings, extensions, charter amendments or adjournments, while the substantive deal flow is concentrated in three pending or approved business combinations (Calisa/Goodvision AI, Charlton Aria/KQC Quantum, and Digital Asset Acquisition/Titan Strategics uranium). The most material developments are Calisa's shareholder approval of its Goodvision AI business combination with strong For votes (5,903,693 For vs 174,200 Against), the Charlton Aria/KQC Quantum investor webcast on October 8 at 10:30 a.m. ET following a October 6 agreement, and the Digital Asset Acquisition/Titan Strategics deal, which carries a $318 million pro-forma enterprise value but unverified SK-1300 drilling data. Newly launched SPACs (Leader's Advantage with $151.1 million in trust; Southport Acquisition Corp. II with $212.1 million in trust) show continued SPAC IPO issuance, though Leader's Advantage carries a going-concern opinion with no target identified. The stream's financial data is limited: the filings do not provide period-over-period financial comparisons, so trend analysis is confined to deal terms, vote tallies, trust sizing and deadlines. Overall, the stream reflects a SPAC ecosystem in which near-term catalysts are deal closings and extension deadlines rather than fundamental earnings momentum.

9 high priority 9 total filings
· daily

US Merger & Acquisition SEC Filings — October 07, 2026

The October 7, 2026, M&A landscape is dominated by two definitive SPAC business combination agreements (First Digital/FDUSD and KQC Quantum) and a major SPAC IPO (Pine Tree Acquisition Corp.), signaling sustained appetite for bringing high-growth, non-traditional assets to public markets via blank-check vehicles. A key period-over-period trend is the divergence in SPAC health: while new capital is flowing into the space via IPOs, existing SPACs like Launch Two and Columbus Acquisition are showing signs of distress, with repeated meeting postponements and opaque post-merger filings, respectively. The most critical development is the $250 million valuation of First Digital, a stablecoin issuer with $87M in FY2025 revenue, which will test regulatory and market appetite for crypto-native public listings. Meanwhile, Richardson Electronics stands out as a rare operating company in the batch, delivering strong 18.9% YoY revenue growth and 112.6% net income surge, contrasting with the speculative nature of the SPAC filings. A portfolio-level pattern is the concentration of risk in SPACs facing tight deadlines (Charlton Aria must close by Oct 25, 2026) and shareholder redemption pressures, creating binary outcomes for investors. The absence of insider trading activity in the SPAC filings, except for the Sponsor's nominal $0.003/share founder share purchase in Southport II, suggests limited management conviction beyond the deal structure itself.

8 high priority 8 total filings
· daily

US Merger & Acquisition SEC Filings — October 06, 2026

This digest covers 23 pre-analyzed SEC filings focused on US M&A and takeover activity, with 14 new filings since the last brief. The period is dominated by several large-scale, transformative transactions: the $691M acquisition of DBM Global by IES Holdings, the $600M divestiture of Clarivate's Life Sciences & Healthcare segment to Altaris, the $31/share take-private of Warner Bros. Discovery by Skydance (now Skydance Corporation), and the Repligen acquisition of BioLife Solutions for $11.25 cash plus stock. A notable trend is the high volume of SPAC activity, with several deals closing or approaching shareholder votes (Columbus Acquisition/WISeSat, Melar/Everli, QuasarEdge/Robseek), while others (Pyrophyte, UY Scuti) extend their timelines, indicating a bifurcated market. Period-over-period data reveals significant financial impacts: Conduent's divestiture of its Public Transit business for $164M is part of a broader portfolio simplification, while Brandywine Realty Trust's $240M office property sale resulted in a $23.6M impairment provision. Insider activity is limited, but the change in control at Tavia Acquisition Corp. (new sponsor Fog Cutter Holdings taking a 25.6% stake) is a key signal. The overall sentiment is mixed, with large strategic deals generating positive momentum for acquirers, offset by high redemption rates in SPACs (56% for Columbus Acquisition) and ongoing governance risks (Adia Nutrition's 50/50 voting split).

23 high priority 23 total filings
· daily

US Merger & Acquisition SEC Filings — October 05, 2026

This digest covers 19 filings centered on US M&A and takeover activity, revealing a market dominated by large-scale strategic consolidations and SPAC maneuvers. A defining theme is the semiconductor sector's consolidation, highlighted by the Skyworks-Qorvo merger, which promises $500M+ in annual cost synergies and immediate EPS accretion, signaling a push for scale and efficiency. Concurrently, significant asset sales are reshaping balance sheets, with GEO Group's $950M facility sale to the US government and INNOVATE Corp.'s $559M divestiture of DBM Global, both aimed at debt reduction and enhanced shareholder returns. The SPAC landscape remains active but pressured, with several entities extending deadlines (Valuence, Launch Two) and one (Spark I) facing shareholder redemptions, while new SPACs like Southport Acquisition Corp. II enter the market with a $200M IPO. A notable trend is the use of litigation settlements for acquisitions, as seen with American Resources Corp. acquiring assets for $40M, and the rise of complex spin-offs, such as Corteva's plan to create Vylor Inc. Overall, the data points to a market prioritizing financial engineering, debt reduction, and strategic refocusing through M&A, with a mix of high-conviction insider moves and cautious capital allocation.

19 high priority 19 total filings
· daily

US Merger & Acquisition SEC Filings — October 02, 2026

The 12 filings reveal a dynamic M&A landscape with a heavy SPAC presence (6 of 12 filings) at various stages—from IPO (Bluerock) to completed business combinations (Columbus/WISeSat) to pending deals with complex PIPE financing (Piermont). Notable large-scale acquisitions include CareTrust REIT's £1.1B UK care home purchase and ESCO Technologies' $2.3B Megger acquisition, both cross-border. EchoStar's DISH DBS emerges from Chapter 11 with a $4.35B debt reduction, strengthening its balance sheet. Key trends: SPACs face shareholder redemption risks and regulatory hurdles (Spark I, Hall Chadwick), while PIPE terms become more aggressive with potential dilution (Piermont). Insider activity is minimal across filings, but sponsor changes (Tavia) and management continuity (Hall Chadwick) provide signals. Overall, the period shows robust M&A activity with a mix of opportunistic acquisitions and distressed restructuring, offering both alpha opportunities and risk flags for investors.

12 high priority 12 total filings